Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sapir

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Neuroscience Letters|July 31, 1989
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated ratsA Fisher, R Brandeis, Z Pittel, et al.
Advances in Neurology|January 1, 1990
AF102B: rational treatment strategy for Alzheimer's disease: recent advancesA Fisher, R Brandeis, I Karton, et al.
Journal of the American Geriatrics Society|March 26, 1998
Ethnicity and decision-makers in a group of frail older peopleC A Hornung, G P Eleazer, H S Strothers, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's diseaseA Fisher, R Brandeis, I Karton, et al.
Journal of the American Geriatrics Society|August 1, 1996
The relationship between ethnicity and advance directives in a frail older populationG P Eleazer, C A Hornung, C B Egbert, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Neuroscience Letters|July 31, 1989
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated ratsA Fisher, R Brandeis, Z Pittel, et al.
Advances in Neurology|January 1, 1990
AF102B: rational treatment strategy for Alzheimer's disease: recent advancesA Fisher, R Brandeis, I Karton, et al.
Journal of the American Geriatrics Society|March 26, 1998
Ethnicity and decision-makers in a group of frail older peopleC A Hornung, G P Eleazer, H S Strothers, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's diseaseA Fisher, R Brandeis, I Karton, et al.
Journal of the American Geriatrics Society|August 1, 1996
The relationship between ethnicity and advance directives in a frail older populationG P Eleazer, C A Hornung, C B Egbert, et al.
Pageof 3